HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meyer, P. T. Articles by Sabri, O. Search for Related Content PubMed PubMed Citation Articles by Meyer, P. T. Articles by Sabri, O.

Investigating Dopaminergic Neurotransmission with ¹²³I-FP-CIT SPECT: Comparability of Modern SPECT Systems

¹ Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany
² Institute of Medicine, Research Center Juelich, Juelich, Germany

With ¹²³I-labeled N--fluoropropyl-2-ß-carbomethoxy-3-ß-(4-iodophenyl)nortropane (FP-CIT) SPECT increasingly gaining access into routine patient care, the comparability of the results of different SPECT systems in the quantification of receptor binding is important for accurate clinical decision making and the translation of imaging results between institutions (e.g., as part of multicenter therapy trials). Methods: In a series of studies using phantoms (containing target cylinders of 2- and 2.8-cm diameter) and ¹²³I-FP-CIT patient studies (n = 49), we compared target-to-background (T/BG) and ¹²³I-FP-CIT striatal uptake ratios recovered by a conventional triple-head SPECT system and a dedicated high-resolution brain SPECT system. All patient studies were acquired on both SPECT systems successively (<15-min interscan gap) using a single-injection protocol (group A [n = 20] was first scanned on the triple-head SPECT system, and group B [n = 29] was first scanned on the dedicated brain SPECT system). Results: In phantom studies, the T/BG ratios recovered by both systems correlated strongly with the true T/BG ratios (R² > 0.96), with the linear regression slopes being 0.86–1.17 and 0.41–0.52 (less steep for smaller target size and lower T/BG ratios) for the dedicated brain SPECT and the triple-head SPECT system, respectively. Although both systems yielded markedly different results, they showed a high linear correlation with each other (R² > 0.95, no significant effect from target size). In ¹²³I-FP-CIT patient studies, a similar linear intersystem correlation was found (R² [A/B] = 0.79/0.80, 0.52/0.68, and 0.83/0.85 for the uptake ratios of the striatum, caudate, and putamen, respectively, to the occipital reference region). Conclusion: A linear transformation of striatal uptake ratios between different SPECT systems appears to be achievable for ligands such as ¹²³I-FP-CIT. An evaluation is needed of whether the present method can do this with sufficient accuracy for clinical purposes or whether methodologic adaptations are necessary. Proper study timing has to be ensured.

Key Words: SPECT • dopamine transporter • reproducibility

This article has been cited by other articles:

				M. P.M. Stokkel, P. Dibbets-Schneider, E. Koestering, C. Dragoiescu, and K. A.K. Blokland Reproducibility of a Standardized Quantitative Analysis Using Fixed Regions of Interest to Differentiate Movement Disorders on 123I-FP-CIT SPECT J. Nucl. Med. Technol., March 1, 2007; 35(1): 21 - 26. [Abstract] [Full Text] [PDF]

				W. Koch, P. E. Radau, C. Hamann, and K. Tatsch Clinical Testing of an Optimized Software Solution for an Automated, Observer-Independent Evaluation of Dopamine Transporter SPECT Studies J. Nucl. Med., July 1, 2005; 46(7): 1109 - 1118. [Abstract] [Full Text] [PDF]

				H. Barthel, S. Hesse, and O. Sabri 123I-{beta}-CIT SPECT for Imaging Serotonin Transporters in Parkinson's Disease J. Nucl. Med., May 1, 2004; 45(5): 923 - 924. [Full Text] [PDF]